Tau - Model 1638

Random Transgenic

Tau (Model 1638) Random Transgenic Mouse Model
Live production of model 1638 will cease by Dec 21, 2018. Consider homozygous Tau model 2508 for future studies.

Mixed Background

  • Model #
  • Genotype
  • Nomenclature
  • 1638-F
    STOCK Tg(Prnp-MAPT*P301L)JNPL3Hlmc
  • 1638-M
    STOCK Tg(Prnp-MAPT*P301L)JNPL3Hlmc
  • 1638-F
    STOCK Tg(Prnp-MAPT*P301L)JNPL3Hlmc
  • 1638-M
    STOCK Tg(Prnp-MAPT*P301L)JNPL3Hlmc
  • Carries the transgene for the human P301L mutation of the microtubule-associated protein tau gene (MAPT)
  • Develops behavioral and motor disturbances related to development of neurofibrillary tangles (NFT)
  • Model for study of Alzheimer's disease, Pick's disease and other neurological syndromes associated with NFT
Orders by weight: Taconic cannot accept orders by weight for this model. Please note that shipments may contain animals with a larger weight variation.

Genetic Background:

C57BL/6, DBA/2, SW Mixed Background


The Tau mouse was developed in the laboratory of Mike Hutton at the Mayo Clinic. The model was created by microinjecting transgenic constructs containing the P301L mutation of the microtubule associated tau gene and mouse prion promoter into B6D2F1 x SW zygotes. The resultant mice from Founder Line JNPL3 were mated to B6D2F1. Taconic received stock in December 2000. The mice were derived by embryo transfer and mated to SW and B6D2F1 hybrids and embryo transfer derived. Offspring from both backgrounds were combined and are mated to B6D2F1 mice to produce hemizygous and wild type mice (1638-T and 1638-W). Hemizygous Tau mice were intercrossed to generate homozygous Tau mice (2508-M). The homozygous colony is maintained by incrossing homozygotes.


Wild type for Nnt mutation; carries Pde6brd1 mutation





Initial Publication:

Lewis J, McGowan E, Rockwood J, Melrose H, Nacaraju P, Van Slegtenhorst M, Gwinn-Hardy K, Murphy MP, Baker M, Yu X, Duff K, Hardy J, Corral A, Lin W-L, Yen S-H, Dickson DW, Davies P, Hutton M. (2000) Neurofibrillary Tangles, Amyotrophy and Progressive Motor Disturbance in Mice Expressing Mutant (P301L) Tau Protein. Nat Genet, 25(4):402-406.

Conditions of Use for Taconic Transgenic Models™
Taconic Transgenic Models™ (Models) are produced and distributed under rights to patents and intellectual property licensed from various institutions. Taconic sells the Models to purchasers, grants to each purchaser a right under Taconic's rights in such licensed patents and intellectual property to use the purchased Model in consideration of purchasers' acknowledgement of and agreement to the Terms and Conditions of Sale and the following terms of use:
  • Title to these Models and biological materials derived from them remains with Taconic Biosciences, Inc.
  • The Models will be used for research purposes only.
  • The Models will not be bred or cross-bred except to obtain embryos or fetuses required for research purposes. This model may be eligible for a cross-breeding agreement. Please contact Taconic Customer Service for details.
  • The Models and biological materials derived from them will not be distributed to third parties or used for commercial purposes.
  • Non-profit purchasers may not use this Model and/or biological materials derived from it in sponsored research or contract research studies unless it is purchased at the for-profit price.
Conditions of Use - Printable Version